CinCor Pharma to Present at Upcoming Investor Conferences
WALTHAM, Mass., May 17, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (NASDAQ: CINC) today announced that management will present at the H.C. Wainwright 2022 Global Investment Conference taking place on May 23-26 virtually and in Miami, Florida, and at the UBS 2022 Global Healthcare Conference taking place on May 23-25 in New York, New York.
The presentation at the H.C. Wainwright Global Investment Conference will be available to conference registrants on-demand beginning Tuesday, May 24, 2022, at 7:00 AM EST.
The live presentation at the UBS Global Healthcare Conference will be on Tuesday, May 24, 2022, at 7:45 AM EST in New York, New York.
The CinCor management team will participate in one-on-one investor meetings during both events. Investors interested in meeting with CinCor at the conference should contact their respective H.C. Wainwright or UBS representatives.
About Baxdrostat (CIN-107)